Ga naar inhoud
Checked.be
Volledig bedrijfsrapport
Gegenereerd 28-06-2026
Actief BE 0406.754.454NV

Eli Lilly Benelux

Markiesstraat 1 ·1000 Brussel, België· 57 jaar actief
Sector: Groothandel (46460)
Conclusie Checked

De berekende faillissementskans van Eli Lilly Benelux over 12 maanden bedraagt 0,5% (laag). Het bedrijf is actief sinds 1969 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.

Op basis van Staatsblad- en KBO-gegevens.
Kerncijfers
Actief 57 jaar
Vestigingen 1
Publicaties 18
Faillissementskans (12 mnd) Checked-model v1 · gratis
0,5% Laag
0%0,5%1,5%4%10%≥25%
Lange historiek −Regio met hoger faalrisico +Rechtsvorm met lager risicoprofiel −

Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?

Risicobeoordeling regelgebaseerd
0 / 100
Laag risico
Vertrouwenssignalen 3 signalen
Lang gevestigd
Opgericht in 1969 — 57 jaar actief.
Geen juridische incidenten
Geen faillissement, reorganisatie of voorlopig bewind in het Belgisch Staatsblad.
Administratief in orde
Geen schrappingen door FOD Economie (UBO, jaarrekeningen, adres, activiteit).
Administratieve waarschuwingen 0 gebeurtenissen
Geen administratieve waarschuwingen
Financiële kerncijfers10 NBB-aangiften
Financiën worden verwerkt
NBB heeft 10 aangifte(n) op record voor dit bedrijf — laatste boekjaar 2024 (volledig). De jaarrekening wordt verwerkt.
Aangiften op record
Boekjaar Type Neerlegging Referentie
31-12-2024 volledig 29-07-2025 2025-00329072
31-12-2023 volledig 19-07-2024 2024-00275198
31-12-2022 volledig 27-07-2023 2023-00278712
31-12-2021 volledig 26-07-2022 2022-20223792
31-12-2020 volledig 20-07-2021 2021-37900138
31-12-2019 volledig 25-08-2020 2020-44700043
31-12-2018 volledig 08-07-2019 2019-31700095
31-12-2017 volledig 04-07-2018 2018-29800094
31-12-2016 volledig 20-07-2017 2017-34400176
31-12-2015 volledig 14-07-2016 2016-32300504
Juridische structuur
NACE primair Groothandel(46460)
Rechtsvorm NV(014)
Oprichtingsdatum19-06-1969
StatusActief
Postcode1000
Vestigingseenheden 1 locatie
Markiesstraat 1, 1000 Brussel
de vervaardiging van meubels voor geneeskundig, tandheelkundig of veeartsenijkundig gebruik : operatietafels, verstelbare bedden voor klinisch gebruik, verstelbare tandartsstoelen
sinds 19692.002.621.517
Fysieke vestigingen geregistreerd in de Kruispuntbank van Ondernemingen (KBO).
Vastgoedvoetafdruk Bron: KBO × kadaster

Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.

Brussel 1 (100%)
Perceel (capakey) Regio Oppervlakte Gebouwen Hoogte / verd.
21804D1348/00E000 Brussel 5.332 m² 1 · 3.876 m² 36,3 m · 10 verd.
Methodologie
via maatschappelijke zetel: 1
1 van 1 percelen met exacte adresmatch; de overige zijn indicatief.
Koppeling op basis van adresgegevens — dit is géén bewijs van eigendom.
Updates 28 gebeurtenissen

Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.

2025
18-09-2025
Staatsblad-akte Bestuurswijziging
v3.2
18-09-2025
Staatsblad-akte Bestuurswijziging
29-07-2025
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2024 · volledig
2024
19-07-2024
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2023 · volledig
01-07-2024
Staatsblad-akte Bestuurswijziging
v3.2
01-07-2024
Staatsblad-akte Bestuurswijziging
2023
05-09-2023
Staatsblad-akte Bestuurswijziging
v3.2
04-09-2023
Staatsblad-akte Statutenwijziging
v3.2
27-07-2023
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2022 · volledig
2022
13-09-2022
Staatsblad-akte Bestuurswijziging
v3.2
26-07-2022
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2021 · volledig
2021
20-07-2021
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2020 · volledig
2020
09-09-2020
Staatsblad-akte Bestuurswijziging
v3.2
25-08-2020
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2019 · volledig
24-01-2020
Staatsblad-akte Bestuurswijziging
v3.2
2019
08-07-2019
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2018 · volledig
06-02-2019
Staatsblad-akte Bestuurswijziging
v3.2
2018
13-07-2018
Staatsblad-akte Bestuurswijziging
v3.2
13-07-2018
Staatsblad-akte Bestuurswijziging
v3.2
04-07-2018
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2017 · volledig
2017
30-11-2017
Staatsblad-akte Bestuurswijziging
v3.2
20-07-2017
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2016 · volledig
21-03-2017
Staatsblad-akte Bestuurswijziging
v3.2
2016
29-08-2016
Staatsblad-akte Bestuurswijziging
v3.2
14-07-2016
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2015 · volledig
23-06-2016
Staatsblad-akte Bestuurswijziging
v3.2
2015
09-12-2015
Staatsblad-akte Bestuurswijziging
v3.2
2004
14-06-2004
Staatsblad-akte Bestuurswijziging
v3.2
Belgisch Staatsblad — aktes 18 aktes
Alle aktes · 18 bijgewerkt 9 maanden geleden
2025
18-09-2025 2 bestuurders benoemd Bestuurswijziging
  • EY Réviseurs d'Entreprises SRL — Commissaire
  • Carlo-Sébastien D'Addario — Représentant permanent du commissaire
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Carlo-S\u00E9bastien D\u0027Addario",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
18-09-2025 4 bestuurders benoemd Bestuurswijziging
  • Carlo-Sébastien D'Addario — Commissaris
  • Carl Meyntjens — Dagelijks bestuur
  • Yannick Sternotte — Dagelijks bestuur
  • Marina Sargsyan — Dagelijks bestuur
Technische details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Carlo-S\u00E9bastien D\u0027Addario",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
        "address": "Kouterveldstraat 7B/1, 1831 Machelen",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les soussign\u00E9s d\u00E9cident de nommer EY R\u00E9viseurs d\u0027Entreprises SRL, dont le si\u00E8ge est situ\u00E9 \u00E0 Kouterveldstraat 7B/1, 1831 Machelen, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9 pour un mandat de trois ans, \u00E0 compter de la date de signature des pr\u00E9sentes d\u00E9cisions.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 3
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "rep_rotation",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Carlo-S\u00E9bastien D\u0027Addario",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
        "address": "Kouterveldstraat 7B/1, 1831 Machelen",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 3:60 du CSA, EY R\u00E9viseurs d\u0027Entreprises SRL d\u00E9signe Monsieur Carlo-S\u00E9bastien D\u0027Addario, r\u00E9viseur d\u0027entreprises, comme repr\u00E9sentant permanent, charg\u00E9 de l\u0027exercice du mandat.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Carl Meyntjens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Simmons \u0026 Simmons LLP",
        "address": "Avenue Louise 143/6, 1050 Bruxelles",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les soussign\u00E9s d\u00E9cident de donner une procuration \u00E0 Carl Meyntjens, Yannick Sternotte, Marina Sargsyan ou tout autre avocat de Simmons \u0026 Simmons LLP, ayant son si\u00E8ge \u00E0 l\u0027Avenue Louise 143/6, 1050 Bruxelles, chacun agissant individuellement et ayant le pouvoir de substitution, pour accomplir toutes l",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Yannick Sternotte",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Simmons \u0026 Simmons LLP",
        "address": "Avenue Louise 143/6, 1050 Bruxelles",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les soussign\u00E9s d\u00E9cident de donner une procuration \u00E0 Carl Meyntjens, Yannick Sternotte, Marina Sargsyan ou tout autre avocat de Simmons \u0026 Simmons LLP, ayant son si\u00E8ge \u00E0 l\u0027Avenue Louise 143/6, 1050 Bruxelles, chacun agissant individuellement et ayant le pouvoir de substitution, pour accomplir toutes l",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Marina Sargsyan",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Simmons \u0026 Simmons LLP",
        "address": "Avenue Louise 143/6, 1050 Bruxelles",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les soussign\u00E9s d\u00E9cident de donner une procuration \u00E0 Carl Meyntjens, Yannick Sternotte, Marina Sargsyan ou tout autre avocat de Simmons \u0026 Simmons LLP, ayant son si\u00E8ge \u00E0 l\u0027Avenue Louise 143/6, 1050 Bruxelles, chacun agissant individuellement et ayant le pouvoir de substitution, pour accomplir toutes l",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-09-18",
    "filing_date": "2025-09-11",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2025-06-30",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Marina Sargsyan",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2024
01-07-2024 3 bestuurders benoemd, 2 ontslagnemend Bestuurswijziging
  • Tinne Glassée — Senior director medical lead
  • Sébastien Massart — Associate director market access & corporate affairs
  • Jan Theuwis — Associate director marketing
  • Elisabeth Van Vleymen — Representant
  • Fanny Verspeelt — Representant
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Representant",
      "person": {
        "rrn": null,
        "name": "Elisabeth Van Vleymen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Senior Director Medical Lead",
      "person": {
        "rrn": null,
        "name": "Tinne Glass\u00E9e",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Representant",
      "person": {
        "rrn": null,
        "name": "Fanny Verspeelt",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Associate Director Market Access \u0026 Corporate Affairs",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Massart",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Associate Director Marketing",
      "person": {
        "rrn": null,
        "name": "Jan Theuwis",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
01-07-2024 3 herbenoemd Bestuurswijziging
  • Tinne Glassée — Directeur
  • Sébastien Massart — Directeur
  • Jan Theuwis — Directeur
Technische details 
{
  "events": [
    {
      "kind": "decharge_granted",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Elisabeth Van Vleymen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide que tous les pouvoirs ayant \u00E9t\u00E9 pr\u00E9c\u00E9demment octroy\u00E9s \u00E0 Elisabeth Van Vleymen, sont r\u00E9voqu\u00E9s avec effet imm\u00E9diat.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Fanny Verspeelt",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide que tous les pouvoirs ayant \u00E9t\u00E9 pr\u00E9c\u00E9demment octroy\u00E9s \u00E0 Fanny Verspeelt sont r\u00E9voqu\u00E9s avec effet imm\u00E9diat.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Tinne Glass\u00E9e",
        "address": null,
        "birth_date": null,
        "profession": "Senior Director Medical Lead",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-04-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide d\u0027octroyer avec effet \u00E0 partir du 12 avril 2024, \u00E0 Tinne Glass\u00E9e, Senior Director Medical Lead (le \u003C Repr\u00E9sentant \u00BB), agissante seule et avec pouvoir de subd\u00E9l\u00E9gation \u00E0 un tiers d\u00E9sign\u00E9 et approuv\u00E9 par M. Fr\u00E9d\u00E9ric Clais, tous pouvoirs afin de poser les actes suivan",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Massart",
        "address": null,
        "birth_date": null,
        "profession": "Associate Director Market Access \u0026 Corporate Affairs",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-04-12",
      "evidence_quote": "Le conseil d\u0027administratior d\u00E9cide d\u0027octroyer avec effet \u00E0 partir du 12 avril 2024, \u00E0 S\u00E9bastien Massart, Associate Director Market Access \u0026 Corporate Affairs (le \u003C Repr\u00E9sentant \u00BB), agissant seul et avec pouvoir de subd\u00E9l\u00E9gation \u00E0 un tiers d\u00E9sign\u00E9 et approuv\u00E9 par M. Fr\u00E9d\u00E9ric Clais, tous pouvoirs afin",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Jan Theuwis",
        "address": null,
        "birth_date": null,
        "profession": "Associate Director Marketing",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-04-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide d\u0027octroyer avec effet \u00E0 partir du 12 avril 2024, et de ratifier tout acte accompli \u00E0 la suite des pouvoirs suivants, \u00E0 Jan Theuwis, Associate Director Marketing (le \u003C\u003C Repr\u00E9sentant \u00BB), agissant seul et avec pouvoir de subd\u00E9l\u00E9gation \u00E0 un tiers d\u00E9sign\u00E9 et approuv\u00E9 pa",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "mandate_confirmation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Tinne Glass\u00E9e",
        "address": null,
        "birth_date": null,
        "profession": "Senior Director Medical Lead",
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide en outre de ratifier tout acte accompli \u00E0 la suite des pouvoirs susmentionn\u00E9s par Tinne Glass\u00E9e \u00E0 partir du 12 avril 2024 jusqu\u0027\u00E0 la date des pr\u00E9sentes r\u00E9solutions.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "mandate_confirmation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Massart",
        "address": null,
        "birth_date": null,
        "profession": "Associate Director Market Access \u0026 Corporate Affairs",
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide en outre de ratifier tout acte accompli \u00E0 la suite des pouvoirs susmentionn\u00E9s par S\u00E9bastien Massart \u00E0 partir du 12 avril 2024 jusqu\u0027\u00E0 la date des pr\u00E9sentes r\u00E9solutions.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "mandate_confirmation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Jan Theuwis",
        "address": null,
        "birth_date": null,
        "profession": "Associate Director Marketing",
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide en outre de ratifier tout acte accompli \u00E0 la suite des pouvoirs susmentionn\u00E9s par Jan Theuwis \u00E0 partir du 12 avril 2024 jusqu\u0027\u00E0 la date des pr\u00E9sentes r\u00E9solutions.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-07-01",
    "filing_date": "2024-06-21",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d\u0027administration",
      "date": "2024-05-23",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Simmons \u0026 Simmons LLP",
    "person_name": null,
    "org_rep_person_name": "Raf Thielemans",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2023
05-09-2023 1 bestuurder benoemd, 1 ontslagnemend Bestuurswijziging
  • Tinne Glassée — Senior director medical shared services
  • Bénédicte Van Maele — Senior director medical shared services
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Senior Director Medical Shared Services",
      "person": {
        "rrn": null,
        "name": "B\u00E9n\u00E9dicte Van Maele",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Senior Director Medical Shared Services",
      "person": {
        "rrn": null,
        "name": "Tinne Glass\u00E9e",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
04-09-2023 Statutenwijziging Statutenwijziging
Samenvatting: v3.2
Technische details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
2022
13-09-2022 Carlo-Sébastien d'Addario benoemd tot commissaire Bestuurswijziging
  • Carlo-Sébastien d'Addario — Commissaire
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Carlo-S\u00E9bastien d\u0027Addario",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2020
09-09-2020 2 bestuurders benoemd Bestuurswijziging
  • Sandrine Ferrière — Bestuurder
  • Frédéric Clais — Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Fr\u00E9d\u00E9ric Clais",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
24-01-2020 3 bestuurders benoemd Bestuurswijziging
  • Sandrine Ferrière — Administrator
  • Frédéric Clais — Administrator
  • Ernst & Young Réviseurs d'Entreprises SC SCRL — Commissaire
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Fr\u00E9d\u00E9ric Clais",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Ernst \u0026 Young R\u00E9viseurs d\u0027Entreprises SC SCRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2019
06-02-2019 2 bestuurders benoemd, 4 ontslagnemend Bestuurswijziging
  • Bénédicte Van Maele — Medical shared services lead
  • Jan-Pieter Claeys — Sales & marketing lead diabetes and oncology belgium
  • Michèle Sangeleer — Medical shared services lead
  • Bert Macken — Sales and marketing leader oncology
  • Egbert Thomas — Area director of elanco benelux and nordic
  • Catherine de Mûelenaere — Head of marketing benelux and nordic
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Medical Shared Services Lead",
      "person": {
        "rrn": null,
        "name": "Mich\u00E8le Sangeleer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Medical Shared Services Lead",
      "person": {
        "rrn": null,
        "name": "B\u00E9n\u00E9dicte Van Maele",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Sales and Marketing Leader Oncology",
      "person": {
        "rrn": null,
        "name": "Bert Macken",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Sales \u0026 Marketing Lead Diabetes and Oncology Belgium",
      "person": {
        "rrn": null,
        "name": "Jan-Pieter Claeys",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Area Director of Elanco Benelux and Nordic",
      "person": {
        "rrn": null,
        "name": "Egbert Thomas",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Head of Marketing Benelux and Nordic",
      "person": {
        "rrn": null,
        "name": "Catherine de M\u00FBelenaere",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2018
13-07-2018 2 bestuurders benoemd Bestuurswijziging
  • Sandrine Ferrière — Bestuurder
  • Frédéric Clais — Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Fr\u00E9d\u00E9ric Clais",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
13-07-2018 2 bestuurders benoemd, 1 ontslagnemend Bestuurswijziging
  • Elisabeth Van Vleymen — Med lead & sr med advisor dermatology
  • Ana Carla Franch — Site engagement manager, clinical operations belgium
  • Kirsten Vandewalle — Regional clinical operations manager
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "Med Lead \u0026 Sr Med Advisor Dermatology",
      "person": {
        "rrn": null,
        "name": "Elisabeth Van Vleymen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "Regional Clinical Operations Manager",
      "person": {
        "rrn": null,
        "name": "Kirsten Vandewalle",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Site Engagement Manager, Clinical Operations Belgium",
      "person": {
        "rrn": null,
        "name": "Ana Carla Franch",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2017
30-11-2017 5 bestuurders benoemd, 9 ontslagnemend Bestuurswijziging
  • Sandrine Ferrière
  • Kirsten Vandewalle — Regional clinical operations manager
  • Bert Macken — Sales and brand manager oncology
  • Jérôme Barey — Manager compta générale, contrôle interne
  • Catherine de Mûelenaere — Head of marketing benelux and nordic
  • Peter Meijer
  • Ana-Carla Franch
  • Bruno van de Pol
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Peter Meijer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Ana-Carla Franch",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Bruno van de Pol",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Gerbert Trommel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Ramiro Cabral",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Hilde Carlier",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Colette Wodon",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Jan-Pieter Claeys",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Egbert Thomas",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Regional Clinical Operations Manager",
      "person": {
        "rrn": null,
        "name": "Kirsten Vandewalle",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Sales and Brand Manager Oncology",
      "person": {
        "rrn": null,
        "name": "Bert Macken",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Manager Compta G\u00E9n\u00E9rale, Contr\u00F4le interne",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Barey",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Head of Marketing Benelux and Nordic",
      "person": {
        "rrn": null,
        "name": "Catherine de M\u00FBelenaere",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
21-03-2017 1 bestuurder benoemd, 1 ontslagnemend Bestuurswijziging
  • Sandrine Ferrière — Bestuurder
  • Lambertus Verbakel — Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Lambertus Verbakel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2016
29-08-2016 Ernst & Young Réviseurs d'Entreprises SC SCRL benoemd tot auditor Bestuurswijziging
  • Ernst & Young Réviseurs d'Entreprises SC SCRL — Auditor
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Ernst \u0026 Young R\u00E9viseurs d\u0027Entreprises SC SCRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
23-06-2016 9 bestuurders benoemd Bestuurswijziging
  • Fanny Verspeelt — Corporate affairs manager
  • Sandrine Ferrière — Hr manager
  • Michèle Sangeleer — Medical director
  • Anne-Pascale Houtekie — Regulatory affairs manager and responsible pharmacist
  • Ana-Carla Franch — Csm leader na
  • Jan-Pieter Claeys — Sales and marketing lead for diabetes
  • Peter Meijer — Business unit manager for oncology
  • Karin Frijns — Customer meeting services associate
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "Corporate Affairs Manager",
      "person": {
        "rrn": null,
        "name": "Fanny Verspeelt",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "HR Manager",
      "person": {
        "rrn": null,
        "name": "Sandrine Ferri\u00E8re",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Medical Director",
      "person": {
        "rrn": null,
        "name": "Mich\u00E8le Sangeleer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Regulatory Affairs Manager and Responsible Pharmacist",
      "person": {
        "rrn": null,
        "name": "Anne-Pascale Houtekie",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "CSM Leader NA",
      "person": {
        "rrn": null,
        "name": "Ana-Carla Franch",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Sales and Marketing Lead for Diabetes",
      "person": {
        "rrn": null,
        "name": "Jan-Pieter Claeys",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Business Unit Manager for Oncology",
      "person": {
        "rrn": null,
        "name": "Peter Meijer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Customer Meeting Services Associate",
      "person": {
        "rrn": null,
        "name": "Karin Frijns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Area Director of Elanco Benelux and Nordic",
      "person": {
        "rrn": null,
        "name": "Egbert Thomas",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2015
09-12-2015 2 bestuurders benoemd, 2 ontslagnemend Bestuurswijziging
  • Frédéric Clais — Bestuurder
  • Frédéric Clais — Gedelegeerd bestuurder
  • Michel Collard — Bestuurder
  • Michel Collard — Gedelegeerd bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Michel Collard",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Fr\u00E9d\u00E9ric Clais",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Michel Collard",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Fr\u00E9d\u00E9ric Clais",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
2004
14-06-2004 1 bestuurder benoemd, 2 ontslagnemend Bestuurswijziging
  • Eric Janvier — Bestuurder
  • Gordon Boyd Coutts — Gedelegeerd bestuurder
  • Gordon Boyd Coutts — Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Gordon Boyd Coutts",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Gordon Boyd Coutts",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eric Janvier",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0406.754.454",
    "name_full": "Eli Lilly Benelux"
  }
}
Krediet-advies advies per klant en bedrag

Mag deze klant voor een bedrag X op factuur kopen? Vul het bedrag en de betalingstermijn in — je krijgt meteen een GROEN/ORANJE/ROOD-advies, met voorgesteld maximum en concrete voorwaarden.

Gebaseerd op officiële bronnen (NBB, KBO, Staatsblad). Indicatief, geen kredietadvies.
AI due-diligence rapport Checked AI

Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.

Binnenkort beschikbaar
AI-gegenereerd op basis van Checked-data; indicatief, geen juridisch of investeringsadvies.
Ondernemingsgegevens (KBO) Kruispuntbank
Activiteiten
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primaire activiteit gemarkeerd.
Namen & handelsnamen
Officiële naamFR Eli Lilly Benelux
Maatschappelijke zetel
Markiesstraat 1
1000 Brussel, België
Officiële gegevens uit de Kruispuntbank van Ondernemingen (KBO). Beschikbaar voor alle geregistreerde ondernemingen.
Vergelijkbare bedrijven Zelfde NACE
Danone Belux BE 0400.774.801 · Brussel
GRACOPA BE 0479.314.810 · Brussel
ICB BE 0462.541.431 · Brussel
Ipsen BE 0422.650.477 · Brussel
SEBRU INVEST BE 0455.642.058 · Brussel
Bron: Belgisch Staatsblad, KBO, NBB · gegenereerd via checked.be · indicatief